|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.15 USD | +0.73% |
|
+0.25% | +4.33% |
| 06-23 | Deutsche Bank Initiates Coverage on DexCom With Buy Rating, $86 Price Target | MT |
| 06-17 | AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 26,490 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 2.34% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 26,085 | 25,279 | 24,269 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | -0.47% | -3.09% | -3.99% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 28x | 23.5x | 19.6x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 9.69x | 8.32x | 6.34x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.6x | 1.2x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.07x | 4.54x | 4.06x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 4.99x | 4.34x | 3.72x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 15.9x | 13.2x | 10.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 21.5x | 17.6x | 14.1x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 26.3x | 20.3x | 16x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.81% | 4.92% | 6.25% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,523 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,639 | 1,915 | 2,228 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,723 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -405 | -1,211 | -2,221 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 68.65 | 68.65 | 68.65 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 10/2/22 | 9/2/23 | 8/2/24 | 13/2/25 | 12/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.05x | 4.99x | 15.91x | -.--% | 26.49B | |
| 23.45x | 3.46x | 13.01x | 2.73% | 162B | |
| 18.38x | 3.2x | 11.28x | 3.68% | 103B | |
| 15.78x | 0.18x | 11.32x | 0.83% | 55.83B | |
| 33.02x | 8.02x | 20.98x | 1.22% | 54.05B | |
| 37.72x | 3x | 10.31x | 2.54% | 41.71B | |
| 36.16x | 1.33x | 11.73x | 0.22% | 31.94B | |
| 41.16x | 7.13x | 25.72x | 0.26% | 24.48B | |
| 23.17x | 3.39x | 12.19x | 1.25% | 20.52B | |
| 23.66x | 3.02x | 12.32x | 1.37% | 20.02B | |
| Average | 28.05x | 3.77x | 14.48x | 1.41% | 54.05B | |
| Weighted average by Cap. | 25.52x | 3.59x | 13.68x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
